Noticias y vídeos - MYLAN N.V.

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris PR Newswire NEW YORK, March 11, 2024 NEW YORK , March 11, 2024 /PRNewswire/ -- IN THE COURT OF COMMON PLEAS OF ALLEGHENY COUNTY, PENNSYLVANIA RAJESH PATEL, Individually and on Behalf of All Others Similarly Situated, Plaintiff, v. VIATRIS, INC., PFIZER...

Fair Fund gaat bepaalde beleggers in Mylan N.V. Common Stock compenseren PR Newswire WASHINGTON, 9 november 2021 WASHINGTON , 9 november 2021 /PRNewswire/ -- RCB Fund Services LLC, de distributieagent voor het Mylan N.V. ("Mylan") Fair Fund (het "Mylan Fair Fund"), maakt bekend dat het compensatieaanvraagproces voor het Mylan Fair Fund is geopend. Het Mylan Fair Fund is opgericht door de United States Securities and Exchange Commission ("SEC") om $ 30 miljoen aan civiele geldboetes uit te keren...

Fairer Fonds zur Entschädigung bestimmter Anleger in Mylan N.V. Stammaktien PR Newswire WASHINGTON, 9. November 2021 WASHINGTON , 9. November 2021 /PRNewswire/ -- RCB Fund Services LLC, die Vertriebsstelle für die Mylan N.V. („Mylan") Fair Fund (der „Mylan Fair Fund"), gibt die Eröffnung des Antragsverfahrens für den Mylan Fair Fund bekannt. Der Mylan Fair Fund wurde von der United States Securities and Exchange Commission („SEC") eingerichtet, um 30 Millionen Dollar an...

Le Fonds Fair indemnisera certains investisseurs dans les actions ordinaires de Mylan N.V. PR Newswire WASHINGTON, 9 novembre 2021 WASHINGTON , 9 novembre 2021 /PRNewswire/ -- RCB Fund Services LLC, l'agent de distribution du Fonds Fair de Mylan N.V. (« Mylan ») (le « Fonds Fair Mylan »), annonce l'ouverture du processus de réclamation auprès du Fonds Fair Mylan. Le Fonds Fair Mylan a été créé par la United States Securities and Exchange Commission (« SEC ») en vue de la distribution...

Fondo Justo para compensar a algunos inversionistas de acciones comunes de Mylan N.V. PR Newswire WASHINGTON, 9 de noviembre de 2021 WASHINGTON , 9 de noviembre de 2021 /PRNewswire/ -- RCB Fund Services LLC, agente de distribución del Fondo Justo Mylan N.V. ("Mylan", el " Fondo Justo Mylan "), anuncia la apertura del proceso de reclamaciones para el Fondo Justo Mylan . El Fondo Justo Mylan fue creado por la Comisión de Bolsa y Valores de los Estados Unidos ("SEC") para distribuir USD 30...

Fair Fund to Compensate Certain Investors in Mylan N.V. Common Stock PR Newswire WASHINGTON, Nov. 9, 2021 WASHINGTON , Nov. 9, 2021 /PRNewswire/ -- RCB Fund Services LLC, the Distribution Agent for the Mylan N.V. ("Mylan") Fair Fund (the "Mylan Fair Fund"), announces the opening of the claims process for the Mylan Fair Fund. The Mylan Fair Fund was established by the United States Securities and Exchange Commission ("SEC") to distribute $30 million in civil money penalties to investors harmed by...

Fair Fund to Compensate Certain Investors in Mylan N.V. Common Stock PR Newswire WASHINGTON, Nov. 9, 2021 WASHINGTON , Nov. 9, 2021 /PRNewswire/ -- RCB Fund Services LLC, the Distribution Agent for the Mylan N.V. ("Mylan") Fair Fund (the "Mylan Fair Fund"), announces the opening of the claims process for the Mylan Fair Fund. The Mylan Fair Fund was established by the United States Securities and Exchange Commission ("SEC") to distribute $30 million in civil money penalties to investors harmed by...

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Viatris Inc. (“Viatris” or “the Company”) (NASDAQ: VTRS ) who formerly held shares of Mylan Inc. (NASDAQ: MYL) for violations of the securities laws. If you are a shareholder who formerly held shares of Mylan, click here to participate . We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los...

Mylan Wins Dismissal of Kansas EpiPen® Direct Purchaser Case PR Newswire PITTSBURGH, July 27, 2021 PITTSBURGH , July 27, 2021 /PRNewswire/ -- Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas granted Mylan's motion to dismiss in a lawsuit brought against it and Pfizer by KPH Healthcare Services, Inc. (KPH) on behalf of an asserted class of direct purchasers of EpiPen ® products. The court agreed with the company's argument that KPH lacked the legal...

Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action Company Confident Evidence Regarding Only Remaining Claim Will Show Mylan's Actions Were Lawful and Pro-competitive PR Newswire PITTSBURGH, June 23, 2021 PITTSBURGH , June 23, 2021 /PRNewswire/ -- Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas ruled, in substantial part, in Mylan's favor on the company's summary judgment motion in the class action related to EpiPen®...

Mylan Wins Summary Judgment in EpiPen® Litigation Brought by Sanofi PR Newswire PITTSBURGH, Dec. 18, 2020 PITTSBURGH , Dec. 18, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas entered summary judgment in Mylan's favor in the lawsuit brought against it by Sanofi related to its EpiPen® products. Viatris is extremely pleased with this significant action by the Court as it rejects Sanofi's baseless attempts to argue that...

Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its financial results for the three and nine months ended September 30, 2020. Third Quarter 2020 Financial Highlights Total revenues of $2.97 billion , a slight increase on an actual basis and a slight decrease on a constant...

Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that Bill Szablewski , CFA, has joined the company as Head of Capital Markets, in a new leadership role working closely with senior leadership. He will be serving in that same capacity for VIATRIS TM...

Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mL Decision clears legal pathway to expand access for patients living with multiple sclerosis in markets across Europe PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Sept. 15, 2020 HERTFORDSHIRE, England and PITTSBURGH , Sept. 15, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that the Technical Board of Appeal of the European Patent Office (EPO) has held that Yeda...

Mylan to Present at the BofA Securities Virtual Global Healthcare Conference PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Sept. 9, 2020 HERTFORDSHIRE, England and PITTSBURGH , Sept. 9, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury , together with President Rajiv Malik will present at the BofA Securities Virtual Global Healthcare Conference on Thursday, Sep. 17, 2020 , at 10:05 a.m. ET / 3:05 p.m. BST ....

Mylan to Acquire Aspen's Thrombosis Business in Europe Acquisition further complements and expands Mylan's complex injectables offering and presence in hospitals Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS™ PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Sept. 8, 2020 HERTFORDSHIRE, England , and PITTSBURGH , Sept. 8, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced an agreement to acquire the related...

Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market PR Newswire HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, Aug. 31, 2020 HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India , Aug. 31, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL)...

Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 28, 2020 HERTFORDSHIRE, England and PITTSBURGH , Aug. 28, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, USP...

Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a First Generic to Tecfidera® PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Aug. 19, 2020 HERTFORDSHIRE, England and PITTSBURGH , Aug. 19, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the launch of the first FDA-approved therapeutically equivalent, substitutable generic of Biogen's Tecfidera ® capsules. Dimethyl fumarate delayed release capsules 120 mg...

ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Mylan N.V. Investors of Important Deadline in Securities Class Action - MYL PR Newswire NEW YORK, Aug. 12, 2020 NEW YORK , Aug. 12, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mylan N.V. (NASDAQ: MYL) between February 16, 2016 and May 7, 2019 , inclusive (the "Class Period"), of the important August 25, 2020 lead plaintiff deadline in securities class action. The lawsuit seeks to...